PTU - Polskie Towarzystwo Urologiczne
list of articles:

Treatment of renal cell carcinoma in the year 2008
Article published in Urologia Polska 2008/61/4.

authors

Janusz Dembowski, Micha³ Wróbel
Katedra i Klinika Urologii i Onkologii Urologicznej Akademii Medycznej we Wroc³awiu

references

  1. Chapman TN, Sharma S, Zhang S et al: Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology 2008, 71, 287-291.
  2. Berger AD, Kanofsky JA, O’Malley RL et al: Transperitoneal laparoscopic radical nephrectomy for large (more than 7 cm) renal masses. Urology 2008, 71, 421-424.
  3. Yossepowitch O, Thompson RH, Leibovich BC et al: Positive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes. J Urol 2008, 179, 2158-2163.
  4. Desai PJ, Andrews PE, Ferrigni RG, Castle EP: Laparoscopic partial nephrectomy at the Mayo Clinic Arizona: follow-up surveillance of positive margin disease. Urology 2008, 71, 283-286.
  5. Nadu A, Mor Y, Laufer M et al: Laparoscopic partial nephrectomy: single center experience with 140 patients – evolution of the surgical technique and its impact on patient outcomes. J Urol 2007, 178, 438-439.
  6. Magera JS, Frank I, Lohse CM et al: Analysis of Repeat Nphron Sparing Surgery as a Treatment Option in Patients With a Solid Mass in a Renal Remnant. J Urol` 2008, 179, 853-856.
  7. Lane BR, Novick AC, Babineau D et al: Comparison of Laparoscopic and Open Partial Nephrectomy for Tumor in a solitary Kidney. J Urol 2008, 179, 847-852.
  8. Turna B, Frota R, Kamoi K et al: Risk factor analysis of postoperative complications in laparoscopic partial nephrectomy. J Urol 2008, 179, 1289-1294.
  9. Martins AC, Cologna AJ, Dias-Neto JA, et al: Renal hypothermia: experience in pigs and clinical trial. J Endourol 2008, 22, 61-64.
  10. Aron M, Gill IS: Partial Nephrectomy – Why, When, How…? J Urol 2008, 179, 811-812.
  11. Bhavani SB: Laparoscopic partial nephrectomy: fifty cases. J Endourol 2008, 22, 313-6.
  12. Lipke MC, Ha SP, Fisher CD et al: Pathologic characteristics of exophytic renal masses. J Endourol 2007, 21, 1489-1491.
  13. Thompson RH, Boorjin SA, Lohse CM et al: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008, 179, 468-471.
  14. Jewett MAS, Zuniga A: Who Will Faille Local Therapy for Renal Cell Carcinoma. J Urol 2008, 179, 2087-2088.
  15. Raj GV, Thompson RH, Leibovich BC et al: Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer. J Urol 2008, 179, 2146-2151.
  16. Gill IS, Kavoussi LR, Lane BR et al: Comparison of 1800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007, 178, 41-46.
  17. Sharma N, O’Hara J, Novick AC et al: Correlation between loss of renal function and loss of renal volume after partial nephrectomy for tumor in a solitary kidney. J Urol 2008, 179, 1284-1288.
  18. Crispen PL, Viterbo R, Fox EB et al: Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 2008, 112, 1051-1057.
  19. Van Poppel H, Joniau S: Is surveillance an option for treatment of small renal masses? Eur Urol 2007, 52, 1323-1330.
  20. Mattar K, Jewett MA: Watchful waiting for small renal masses. Curr Urol Rep 2008, 9, 22-25.
  21. Kunkle DA, Egleston BL, Uzzo RG: Excise, ablate or observe: the small renal mass dilemma – a meta-analysys and review. J Urol 2008, 179, 1233-1234.
  22. Rogers CG, Singh A, Blatt AM et al: Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol 2008, 53, 514-521.
  23. Klinger HC, Susani M, Seip R et al: A novel approach to energy ablative therapy of small renal tumours: laparoscopic high-intensity focusedultrasound. Eur Urol 2008, 53, 810-818.
  24. Bensalah K, Zeltser I, Tuncel A et al: Evaluation of costs and morbidity associated with laparoscopic radiofrequency ablation and laparoscopic partial nephrectomy for treating small renal tumors. BJU Int 2008, 101, 467-471.
  25. Pandharipande PV, Gervais DA, Mueller PR et al: Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology 2008, 248, 169-178.
  26. Raman JD, Stern JM, Zeltser I et al: Absence of Viable Renal Carcinoma in Biopsies Performed More than 1 Year Following Radio Frequency Ablation Confirms Reliability of Axial Imaging. J Urol 2008, 179, 2142-2145.
  27. Weigh CJ, Kaouk JH, Hegarty NJ et al: Correlation of Radiographic Imaging and Histopathology Following Cryoablation and Radio Frequncy Ablation for Renal Tumors. J Urol 2008, 179, 1277-1281.
  28. Wessels JT, Busse AC, Rave-Fränk M et al: Photosensitizing and radiosensitizing effects of hypericin on human renal carcinoma cells in vitro. Photochem Photobiol 2008, 84, 228-235.
  29. Matin SF, Tinkey PT, Borne AT et al: A pilot trial of vascular targeted photodynamic therapy for renal tissue. J Urol 2008, 180, 338-342.
  30. Atwell TD, Farrel MA, Callstrom MR et al: Percutaneous Cryoablation of 40 Solid Renal Tumors with US Guidance and CT Monitoring: Initial Experience. Radiol 2007, 243, 276-283.
  31. Atwell TD, Farrel MA, Leibovich BC et al: Percutaneous renal cryoablation: experience treating 115 tumors. J Urol 2008, 179, 2136-2140.
  32. Badwan K, Maxwell K, Venkatesh R et al: Comparison of laparoscopic and percutaneous cryoablaion of renal tumors: a cost analysis. J Endourol 2008, 22, 1275-1277.
  33. O’Malley RL, Berger AD, Kanosfsky JA et al: A matched-cohort comparison of laparoscopic cryablation and laparoscopic partial nephrectomy for treating renal masses. BJU Int 2007, 99, 395-398
  34. Lin YC, Turna B, Frota R et al: Laparoscopic partial nephrectomy versus leperoscopic cryoablation for multiple ipslateral renal tumors. Eur Urol 2008, 53, 1210-1216.
  35. Van der Veldt AA, Meijerink MR, van den Eertwegh AJ et al: Sunitinib for treatment of advanced renal cell cancer: pimary tumor response. Clin Cancer Res 2008, 14, 2431-2436.
  36. Heng DY, Rini BI, Garcia J et al: Prolonged complete responses and nearcomplete responses to sunitinib in metastatic renal cell carcinoma. Clin Genitourin Cancer 2007, 5, 446-451.
  37. Tamaskar I, Garcia JA, Elson P et al: Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy. J Urol 2008, 179, 81-86.
  38. Choueiri TK, Plantade A, Elson P et al: Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma. J Clin Oncol 2008, 26, 127-131.
  39. Koutras AK, Krikelis D, Alexandrou N et al: Brain metastases in renal cell cancer responding to sunitinib. Anticancer Res 2007, 27, 4255-4257.
  40. Gay HA, Cavalieri R, Allison RR, at al: Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy. Dermatol Online J 2007, 13, 62-64.
  41. Thibault F, Izzedine H, Sultan V et al: Regression o vena cava tumour thrombus in response to sorafenib. Prog Urol 18, 480-482.
  42. Di Silverio F, Sciarra A, Parente U et al: Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy. Urol. Int 2008, 80, 451-453.
  43. Chu D, Lacouture ME, Fillos T, Wu S: Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis. Acta Oncol 2008, 47, 176-186.
  44. Lountzis NI, Maroon MS: Sorafenib-induced palmoplantaer hyperkeratosis. J Drugs Dermatol 2008, 7, 588-589.
  45. Rixie O, Bukowski RM, Michaelson MD et al: Axitinib treatment in patients with cytokine refractory metastatic renal-cell cancer: a phase II study. Lancet Oncol 2007, 8, 975-984.
  46. Sonpavde G, Hutson TE, Sternberg CN: Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma. Expert Opin Investig Drugs 2008, 17, 253-261.
  47. Ravaud A, Hawkins R, Gardner JP et al: Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial. J Clin Oncol 2008, 26, 2285-22891.
  48. Hudes G, Carducci M, Tomczak P et al: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007, 356, 2271-2281.
  49. Hainsworth JD, Spigel DR, Sosman JA et al: Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II tria. Clin Genitourin Cancer 2007, 5, 427-432.
  50. Escudier B, Pluzanska A, Koralewski P et al: Bevacizumab plus interferon alfa 2a for treatment of metastatic renal cell carcinoma: a randomized, double-blind phase III trial. Lancet 2007, 370, 2103-2111.

correspondence

Janusz Dembowski
Klinika Urologii i Onkologii Urologicznej
ul. Borowska 213
50-556 Wroc³aw
(071) 733 10 10
j.dembowski@op.pl